Daniela Oliveira de Melo

Non-Communicable Disease Clinical Practice Guidelines in Brazil: A Systematic Assessment of Methodological Quality and Transparency

Caroline de Godoi Rezende Costa Molino, Nicolina Silvana Romano-Lieber, Eliane Ribeiro et al. · PLoS ONE · 2016 · 48 citations · Full text

High quality (certainty) evidence changes less often than low‐quality evidence, but the magnitude of effect size does not systematically differ between studies with low versus high‐quality evidence

Benjamin Djulbegović, Muhammad Muneeb Ahmed, Iztok Hozo et al. · Journal of Evaluation in Clinical Practice · 2022 · 24 citations · Full text

Counseling, Evidence-based Intervention, Effect Size +25

Potential kidney damage associated with the use of remdesivir for COVID-19: analysis of a pharmacovigilance database

Nayara Aparecida de Oliveira Silva, Ana Laura de Sene Amâncio Zara, Albert Figueras et al. · Cadernos de Saúde Pública · 2021 · 22 citations · Full text

Renal Pathology, Renal Inflammation, Potential Kidney Damage +23

Haptoglobin polymorphism in a HIV-1 seropositive Brazilian population

Tânia Regina Zaccariotto, Endrigo Torezan Rosim, Daniela Oliveira de Melo et al. · Journal of Clinical Pathology · 2006 · 16 citations · Full text

Vancomycin use in a hospital with high prevalence of Methicillin-Resistant Staphylococcus aureus: comparison with Hospital Infection Control Practices Advisory Committe Guidelines (HICPAC)

Daniela Oliveira de Melo, Marli Sasaki, Renato Satovschi Grinbaum · The Brazilian Journal of Infectious Diseases · 2007 · 13 citations · Full text